search
Back to results

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Primary Purpose

Diabetes Mellitus Type 2

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
metformin
pioglitazone
placebo
taspoglutide
taspoglutide
Sponsored by
Hoffmann-La Roche
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus Type 2

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • adult patients, 18-75 years age;
  • type 2 diabetes receiving pioglitazone (>= 30 mg/day) and metformin (>= 1500 mg/day) for at least 12 weeks prior to screening;
  • HbA1c >=7.0% and <=10.0% at screening;
  • BMI >= 25 (>23 for Asians) and <=45 kg/m2 at screening;
  • stable weight +/-5% for at least 12 weeks prior to screening.

Exclusion Criteria:

  • history of type 1 diabetes mellitus or acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma in the previous 6 months;
  • evidence of clinically significant diabetic complications;
  • clinically symptomatic gastrointestinal disease;
  • myocardial infarction, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within the previous 6 months;
  • known hemoglobinopathy or chronic anemia.

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Experimental

Experimental

Arm Label

Placebo

Taspoglutide 10mg

Taspoglutide 10mg/20mg

Arm Description

Placebo in addition to continued stable metformin plus pioglitazone treatment. After the first 24 weeks patients on placebo will be switched to taspoglutide 10mg once weekly or taspoglutide 20mg once weekly (after 4 weeks of taspoglutide 10mg once weekly.

Taspoglutide 10mg once weekly in addition to continued stable metformin plus pioglitazone treatment

Taspoglutide 20 mg once weekly (after 4 weeks of taspoglutide 10 mg once weekly) in addition to continued stable metformin plus pioglitazone treatment.

Outcomes

Primary Outcome Measures

Absolute change from baseline in HbA1c

Secondary Outcome Measures

Change from baseline in fasting plasma glucose; change from baseline in body weight; responder rates for HbA1c (target <=7.0%, <=6.5%); responder rates for body weight; beta cell function.
Safety: adverse events, vital signs, physical examination, clinical laboratory tests, ECG and anti-taspoglutide antibodies.

Full Information

First Posted
August 29, 2008
Last Updated
August 3, 2016
Sponsor
Hoffmann-La Roche
search

1. Study Identification

Unique Protocol Identification Number
NCT00744367
Brief Title
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Official Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability and Effect of Taspoglutide on Glycemic Control Compared to Placebo in Patients With Type II Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
October 2008 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hoffmann-La Roche

4. Oversight

5. Study Description

Brief Summary
This 3 arm study will assess the efficacy of taspoglutide on glycemic control (as assessed by HbA1c) in patients with type 2 diabetes mellitus inadequately controlled with metformin plus pioglitazone, compared to placebo after 24 weeks of treatment. Patients will be randomized to one of 3 treatment arms: taspoglutide 10mg once weekly, taspoglutide 20 mg once weekly (after 4 weeks of taspoglutide 10 mg once weekly) or placebo, in addition to their continued stable metformin plus pioglitazone treatment. After the first 24 weeks patients on placebo will be switched to taspoglutide 10mg once weekly or taspoglutide 20mg once weekly (after 4 weeks of taspoglutide 10mg once weekly. The anticipated time on study treatment is 1-2 years, and the target sample size is 100-500 individuals.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus Type 2

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
326 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo in addition to continued stable metformin plus pioglitazone treatment. After the first 24 weeks patients on placebo will be switched to taspoglutide 10mg once weekly or taspoglutide 20mg once weekly (after 4 weeks of taspoglutide 10mg once weekly.
Arm Title
Taspoglutide 10mg
Arm Type
Experimental
Arm Description
Taspoglutide 10mg once weekly in addition to continued stable metformin plus pioglitazone treatment
Arm Title
Taspoglutide 10mg/20mg
Arm Type
Experimental
Arm Description
Taspoglutide 20 mg once weekly (after 4 weeks of taspoglutide 10 mg once weekly) in addition to continued stable metformin plus pioglitazone treatment.
Intervention Type
Drug
Intervention Name(s)
metformin
Intervention Description
>1500 mg/day or maximum tolerated dose (MTD)
Intervention Type
Drug
Intervention Name(s)
pioglitazone
Intervention Description
>= 30 mg/day
Intervention Type
Drug
Intervention Name(s)
placebo
Intervention Description
sc once weekly
Intervention Type
Drug
Intervention Name(s)
taspoglutide
Intervention Description
10 mg sc once weekly;
Intervention Type
Drug
Intervention Name(s)
taspoglutide
Intervention Description
20 mg sc once weekly (after 4 weeks of taspoglutide 10 mg sc once weekly)
Primary Outcome Measure Information:
Title
Absolute change from baseline in HbA1c
Time Frame
24 weeks
Secondary Outcome Measure Information:
Title
Change from baseline in fasting plasma glucose; change from baseline in body weight; responder rates for HbA1c (target <=7.0%, <=6.5%); responder rates for body weight; beta cell function.
Time Frame
24 weeks
Title
Safety: adverse events, vital signs, physical examination, clinical laboratory tests, ECG and anti-taspoglutide antibodies.
Time Frame
Throughout the study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adult patients, 18-75 years age; type 2 diabetes receiving pioglitazone (>= 30 mg/day) and metformin (>= 1500 mg/day) for at least 12 weeks prior to screening; HbA1c >=7.0% and <=10.0% at screening; BMI >= 25 (>23 for Asians) and <=45 kg/m2 at screening; stable weight +/-5% for at least 12 weeks prior to screening. Exclusion Criteria: history of type 1 diabetes mellitus or acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma in the previous 6 months; evidence of clinically significant diabetic complications; clinically symptomatic gastrointestinal disease; myocardial infarction, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within the previous 6 months; known hemoglobinopathy or chronic anemia.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clinical Trials
Organizational Affiliation
Hoffmann-La Roche
Official's Role
Study Director
Facility Information:
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35209
Country
United States
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35294
Country
United States
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35801
Country
United States
City
Muscle Shoals
State/Province
Alabama
ZIP/Postal Code
35661
Country
United States
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85028
Country
United States
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85032
Country
United States
City
Buena Park
State/Province
California
ZIP/Postal Code
90620
Country
United States
City
Lancaster
State/Province
California
ZIP/Postal Code
93534
Country
United States
City
Loma Linda
State/Province
California
ZIP/Postal Code
92354
Country
United States
City
Rancho Cucamonga
State/Province
California
ZIP/Postal Code
91730
Country
United States
City
Roseville
State/Province
California
ZIP/Postal Code
95661
Country
United States
City
San Diego
State/Province
California
ZIP/Postal Code
92161
Country
United States
City
Walnut Creek
State/Province
California
ZIP/Postal Code
94598
Country
United States
City
Wheatridge
State/Province
Colorado
ZIP/Postal Code
80033
Country
United States
City
Hamden
State/Province
Connecticut
ZIP/Postal Code
06518
Country
United States
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20017
Country
United States
City
Bradenton
State/Province
Florida
ZIP/Postal Code
34208
Country
United States
City
Chiefland
State/Province
Florida
ZIP/Postal Code
32626
Country
United States
City
Fort Myers
State/Province
Florida
ZIP/Postal Code
33907
Country
United States
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32607
Country
United States
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33021
Country
United States
City
Miami
State/Province
Florida
ZIP/Postal Code
33136
Country
United States
City
New Port Richey
State/Province
Florida
ZIP/Postal Code
34652
Country
United States
City
Ocala
State/Province
Florida
ZIP/Postal Code
34474
Country
United States
City
Plantation
State/Province
Florida
ZIP/Postal Code
33317
Country
United States
City
Tampa
State/Province
Florida
ZIP/Postal Code
33614
Country
United States
City
Nampa
State/Province
Idaho
ZIP/Postal Code
83687
Country
United States
City
Aurora
State/Province
Illinois
ZIP/Postal Code
60504
Country
United States
City
Libertyville
State/Province
Illinois
ZIP/Postal Code
60048
Country
United States
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
City
Des Moines
State/Province
Iowa
ZIP/Postal Code
50314
Country
United States
City
Topeka
State/Province
Kansas
ZIP/Postal Code
66614
Country
United States
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40504
Country
United States
City
Madisonville
State/Province
Kentucky
ZIP/Postal Code
42431
Country
United States
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70121
Country
United States
City
Frederick
State/Province
Maryland
ZIP/Postal Code
21702
Country
United States
City
Oxon Hill
State/Province
Maryland
ZIP/Postal Code
20745
Country
United States
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
City
Ferndale
State/Province
Michigan
ZIP/Postal Code
48220
Country
United States
City
Kalamazoo
State/Province
Michigan
ZIP/Postal Code
49048
Country
United States
City
Biloxi
State/Province
Mississippi
ZIP/Postal Code
39531
Country
United States
City
Olive Branch
State/Province
Mississippi
ZIP/Postal Code
38654
Country
United States
City
St Peters
State/Province
Missouri
ZIP/Postal Code
63376
Country
United States
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68114
Country
United States
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68131
Country
United States
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89148
Country
United States
City
Albany
State/Province
New York
ZIP/Postal Code
12206-1098
Country
United States
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11218
Country
United States
City
Hudson
State/Province
New York
ZIP/Postal Code
12534
Country
United States
City
Lake Success
State/Province
New York
ZIP/Postal Code
11042
Country
United States
City
Staten Island
State/Province
New York
ZIP/Postal Code
10301
Country
United States
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28262
Country
United States
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28277
Country
United States
City
Mooresville
State/Province
North Carolina
ZIP/Postal Code
28117
Country
United States
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
City
Bismarck
State/Province
North Dakota
ZIP/Postal Code
58501
Country
United States
City
Athens
State/Province
Ohio
ZIP/Postal Code
45701
Country
United States
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
City
Kettering
State/Province
Ohio
ZIP/Postal Code
45429
Country
United States
City
Norman
State/Province
Oklahoma
ZIP/Postal Code
73071
Country
United States
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States
City
Beaver
State/Province
Pennsylvania
ZIP/Postal Code
15009
Country
United States
City
Bensalem
State/Province
Pennsylvania
ZIP/Postal Code
19020
Country
United States
City
Carlisle
State/Province
Pennsylvania
ZIP/Postal Code
17015
Country
United States
City
Levittown
State/Province
Pennsylvania
ZIP/Postal Code
19056
Country
United States
City
Melrose Park
State/Province
Pennsylvania
ZIP/Postal Code
19027
Country
United States
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15236
Country
United States
City
Cranston
State/Province
Rhode Island
ZIP/Postal Code
02920
Country
United States
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29651
Country
United States
City
Bellaire
State/Province
Texas
ZIP/Postal Code
77401
Country
United States
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78205
Country
United States
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84102
Country
United States
City
Federal Way
State/Province
Washington
ZIP/Postal Code
98003
Country
United States
City
Brasilia
ZIP/Postal Code
70390-155
Country
Brazil
City
Forlateza
ZIP/Postal Code
60430-350
Country
Brazil
City
Fortaleza
ZIP/Postal Code
60120-021
Country
Brazil
City
Fortaleza
ZIP/Postal Code
60155-290
Country
Brazil
City
Fortaleza
ZIP/Postal Code
60430-370
Country
Brazil
City
Mogi Das Cruzes - Sp
ZIP/Postal Code
08780-090
Country
Brazil
City
Passo Fundo
ZIP/Postal Code
99010-901
Country
Brazil
City
Porto Alegre
ZIP/Postal Code
90035-001
Country
Brazil
City
Recife
ZIP/Postal Code
50100-130
Country
Brazil
City
Sao Paulo
ZIP/Postal Code
01221-020
Country
Brazil
City
Sao Paulo
ZIP/Postal Code
01244-030
Country
Brazil
City
Sao Paulo
ZIP/Postal Code
04022-001
Country
Brazil
City
Sao Paulo
ZIP/Postal Code
05403-000
Country
Brazil
City
Mount Pearl
State/Province
Newfoundland and Labrador
ZIP/Postal Code
A1N 1W7
Country
Canada
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 3Z5
Country
Canada
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5R8
Country
Canada
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M9W 4L6
Country
Canada
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H2W 1T8
Country
Canada
City
Pointe-claire
State/Province
Quebec
ZIP/Postal Code
H9R 4S3
Country
Canada
City
San Jose
ZIP/Postal Code
755-1000
Country
Costa Rica
City
Bondy
ZIP/Postal Code
93143
Country
France
City
Dijon
ZIP/Postal Code
21079
Country
France
City
Nantes
ZIP/Postal Code
44093
Country
France
City
Narbonne
ZIP/Postal Code
11108
Country
France
City
Falkensee
ZIP/Postal Code
14612
Country
Germany
City
Karlsruhe
ZIP/Postal Code
76199
Country
Germany
City
Mainz
ZIP/Postal Code
55116
Country
Germany
City
Neuwied
ZIP/Postal Code
56564
Country
Germany
City
Potsdam
ZIP/Postal Code
14469
Country
Germany
City
Guatemala
ZIP/Postal Code
01010
Country
Guatemala
City
Guatemala
Country
Guatemala
City
Chihuahua
ZIP/Postal Code
31238
Country
Mexico
City
Jalisco
ZIP/Postal Code
44690
Country
Mexico
City
Mexico City
ZIP/Postal Code
11650
Country
Mexico
City
Carolina
ZIP/Postal Code
00983
Country
Puerto Rico
City
Guyanabo, San Juan
ZIP/Postal Code
00920
Country
Puerto Rico
City
San Juan
ZIP/Postal Code
00926-2832
Country
Puerto Rico

12. IPD Sharing Statement

Learn more about this trial

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

We'll reach out to this number within 24 hrs